Clinical Trial Group
Lead : Prof Fahal
Coordinator: Dr. Eiman Saddig
Subgroups
- Double-blind, randomized clinical trial for eumycetoma treatment using fosravuconazole, versus the current standard of care, daily treatment with itraconazole.
MRC- DNDi - Eisai Ltd (Japan) Group Members
Diagnostics Research Group
Lead: Dr. Sahar Mubarak
Coordinator :Mr. Emmanuel Edwar Siddig
Subgroups
- Development of field-friendly point-of-care diagnostic test for mycetoma
MycEXomics Members - Protein Biobank
MRC - Biochemistry Department, Faculty of Medicine, U of K Group Members - Eumycetoma molecular diagnosis
MRC - Erasmus Medical Centre Group Members - Actinomycetoma molecular diagnosis
MRC - Erasmus Medical Centre Group Members - In Vitro drugs sensitivity testing
MRC - Erasmus Medical Centre Group Members - Fosravuconazole pharmacodynamics for Eumycetoma Treatment
MRC - Erasmus Medical Centre Group Members
Epidemiology Research Group
Lead: Prof Fahal
Coordinator : Dr. Sahar Mubarak
Subgroups
- Mycetoma Spatial distribution
MRC - NIHR Global Health Research Unit Members - Mycetoma Genetics
MRC - NIHR Global Health Research Unit Members - Mycetoma spatial distruation at Eastern Sennar
MRC - Nagasaki University. Japan Group Members - Mycetoma transmission route and vector control
MRC - Vector Genetics and Control Laboratory, Faculty of Science, University of Khartoum Group Members - Mycetoma Spatial distribution in Sudan
MRC - Faculty of Geographical and Environmental Sciences, University of Khartoum Group Members
Social Sciences Research Group
Lead : Dr. Osama Abu Zaid
Dr Azza Ahmed A AZZIZ
Coordinator: Dr. Hala EL Malik
Subgroups
- The Social Sciences for Severe Stigmatising Skin Conditions (5S) Foundation Project
MRC - 5 S Foundation Members - Mycetoma Social Impact
MRC - NIHR Global Health Research Unit Members
Immunopathology Research Group
Lead: Prof. Ahmed Mudawi Musa
Coordinator: Dr. Sahar Mubarak
Subgroups
- Digital Spatial Profiling of the immune- microenvironment in the mycetoma granulomas
MRC - Immunity and Infection Centre, York University - Immune responses of mycetoma patients during a double-blind, randomized clinical trial for eumycetoma treatment using fosravuconazole, versus the current standard of care, daily treatment with itraconazole.
MRC- DNDi - Eisai Ltd (Japan) Group Members
Mycetoma Mathematical Modeling
Lead: Prof. Fahal
Coordinator: Miss Hayman
Subgroups
- The mathematical modelling for the histopathological diagnosis of Mycetoma
MRC – Tours University, France Group Members - The mathematical modelling for the mycetoma treatment outcome
MRC - Faculty of Mathematical Sciences, U of K, Group Members
Mycetoma Therapeutic Research Group
Lead: Prof. Magdi Hussein
Coordinator:
Subgroups
- Drug repurposing for mycetoma
MRC – Tours University, France Group Members